Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

436 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.
Matsuzaki A, Ishii E, Nagatoshi Y, Eguchi H, Koga H, Yanai F, Inada H, Nibu K, Tamai Y, Akiyoshi K, Nakayama H, Hara T, Take H, Miyazaki S, Okamura J. Matsuzaki A, et al. Among authors: inada h. Int J Hematol. 2001 Apr;73(3):369-77. doi: 10.1007/BF02981964. Int J Hematol. 2001. PMID: 11345205 Review.
Clinical characteristics and genetic analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: a Japanese retrospective study by the Kyushu-Yamaguchi Children's Cancer Study Group.
Moritake H, Kamimura S, Nunoi H, Nakayama H, Suminoe A, Inada H, Inagaki J, Yanai F, Okamoto Y, Shinkoda Y, Shimomura M, Itonaga N, Hotta N, Hidaka Y, Ohara O, Yanagimachi M, Nakajima N, Okamura J, Kawano Y. Moritake H, et al. Among authors: inada h. Int J Hematol. 2014 Jul;100(1):70-8. doi: 10.1007/s12185-014-1591-1. Epub 2014 May 15. Int J Hematol. 2014. PMID: 24827398
Treatment of standard-risk acute lymphoblastic leukemia in children: the results of protocol AL841 from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A, Okamura J, Ishii E, Ikuno Y, Koga H, Eguchi H, Yanai F, Inada H, Nibu K, Hara T, Take H, Miyazaki S, Tasaka H. Matsuzaki A, et al. Among authors: inada h. Pediatr Hematol Oncol. 1999 May-Jun;16(3):187-99. doi: 10.1080/088800199277245. Pediatr Hematol Oncol. 1999. PMID: 10326217 Clinical Trial.
Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: a report from the Kyushu-Yamaguchi Children's Cancer Study group in Japan.
Matsuzaki A, Eguchi H, Ikuno Y, Ayukawa H, Yanai F, Ishii E, Sugimoto T, Inada H, Anami K, Nibu K, Hara T, Miyazaki S, Okamura J. Matsuzaki A, et al. Among authors: inada h. Pediatr Hematol Oncol. 2000 Dec;17(8):623-34. doi: 10.1080/08880010050211330. Pediatr Hematol Oncol. 2000. PMID: 11127394 Clinical Trial.
Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
Suita S, Kinoshita Y, Tajiri T, Hara T, Tsuneyoshi M, Mizote H, Inada H, Takamatsu H, Kawano Y, Inomata Y, Nagasaki A, Ono Y, Handa N, Okamura J, Ishii E, Kawakami K; Committee for pediatric solid malignant tumors in the Kyushu area. Suita S, et al. Among authors: inada h. J Pediatr Surg. 2006 Sep;41(9):1501-5. doi: 10.1016/j.jpedsurg.2006.05.008. J Pediatr Surg. 2006. PMID: 16952581
Randomized trial to compare LSA2L2-type maintenance therapy to daily 6-mercaptopurine and weekly methotrexate with vincristine and dexamethasone pulse for children with acute lymphoblastic leukemia.
Nagatoshi Y, Matsuzaki A, Suminoe A, Inada H, Ueda K, Kawakami K, Yanai F, Nakayama H, Moritake H, Itonaga N, Hotta N, Fujita K, Hidaka Y, Yamanaka T, Kawano Y, Okamura J. Nagatoshi Y, et al. Among authors: inada h. Pediatr Blood Cancer. 2010 Aug;55(2):239-47. doi: 10.1002/pbc.22528. Pediatr Blood Cancer. 2010. PMID: 20582970 Clinical Trial.
436 results